Så fik Trump ret ENDNU en gang: en epidemolog fra Yale dokumenterer at hydroklorokin VIRKER !

Det skal bare gives sammen med azithromycin og zink og i begyndelsen af sygdommen …

Den anerkendte epidemiolog Dr. Harvey Risch har undersøgt 5 studier, inclusive 2 kontollerede kliniske forsøg, der viser at hydroklorokin sammen med azithromycin og zink har en særdeles god virkning på corona patienter, når det gives i begyndelsen af sygdommen !

Her er en video med Laura Ingraham om det – hop hen til ca 36:05 :

Jeg har fundet afhandlingen her

Hvornår vil fake-news-MSM give Trump en undskyldning ???

Vi kender godt svaret på det spørgsmål = aldrig

her er studie 1:

Thus for example, studies of chloroquine or HCQ used alone do not bear upon evidence
for efficacy of HCQ+AZ or HCQ+doxycycline. This point has been argued forcefully by the
French doctors (20). The first study of HCQ+AZ (24) was controlled but not randomized or
blinded, and involved 42 patients in Marseilles, France. This study showed a 50-fold benefit of
HCQ+AZ vs standard-of-care, with P-value=.0007

og her studie 2:

A second study of the Marseilles group (27) involved 1061 patients tested positive for
SARS-CoV-2 and treated with HCQ+AZ for at least 3 days and followed for at least 9 days. The
were seen in 973 patients (92%). Five patients died, and the remainder were in various stages of
recovery.

og studie 3:

The third piece of evidence involves the cohort of 1450 patients treated by Dr. Vladimir
Zelenko of Monsey, NY. Dr. Zelenko has released a two-page report (28) describing his clinical
reasoning and procedures, dosing conditions and regimen, and patient results through April 28.
Symptomatic patients presenting to Dr. Zelenko were treated with five days of HCQ+AZ+zinc
ED
sulfate if they were considered high-risk, as evidenced by one or more of: age 60 years or older;
high-risk comorbidities; body-mass index>30; mild shortness of breath at presentation. Patients
were considered to have Covid-19 based on clinical grounds and started treatment as soon as
possible following symptom onset, rather than delaying for test results before starting treatment.
Of the 1450 patients, 1045 were classified as low-risk and sent home to recuperate without active
medications. No deaths or hospitalizations occurred among them. Of the remaining 405 treated
with the combined regimen, 6 were ultimately hospitalized and 2 died. No cardiac arrhythmias
were noted in these 405 patients.

Og studie 4:

The fourth relevant study was a controlled non-randomized trial of HCQ+AZ in 636
symptomatic high-risk outpatients in São Paulo, Brazil (29). All consecutive patients were
informed about the utility and safety profile of the medications and offered the treatment, and
those who declined (n=224) comprised the control group. Patients were monitored daily by
telemedicine. The study outcome was need for hospitalization, defined as clinically worsening
condition or significant shortness of breath (blood oxygen saturation <90%). Even though the

(resten af studie 4 kunne jeg ikke klippe, så du må nøjes med et skærmklip)

Og studie 5:

Finally, a small study is ongoing in a long-term care facility in Long Island, NY. This
study has been employing HCQ+doxycycline rather than HCQ+AZ for treatment of high-risk
ED
Covid-19 patients. Doxycycline itself has antiviral activity against SARS-CoV-2 at in vitro
concentrations 5.6μM median (30). Among the first 54 residents treated in the Long Island
study, 6 were hospitalized and 3 (5.6%) died (31). An unofficial update of these data indicates
that of about 200 high-risk patients treated with HCQ+doxycycline, 9 (4.5%) have died.

Jeg havde igen lidt klippe problemer pga at hver side har et vandmærke med “foreløbig”

Så her er altså bla 2 klinisk kontrollerede forsøg.

Så kan vi – måske – slippe for de politisk korrektes Trump Derangement Syndrome med at nedgøre det billige OG effektive middel ??

De vil jo hellere brække en arm end at give Trump ret og redde menneskeliv …

(meme:)

her er en anden video om emnet:

Be the first to comment

Leave a Reply

Din email adresse vil ikke blive vist offentligt.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.